Direct-acting antivirals
74 articles
“Quick, Simple, and Friendly”: Understanding the Acceptability and Accessibility of a Nurse and Peer-Led, Mobile Model of Hepatitis C Care Adjacent to Community Corrections in Australia
The C No More study is a pilot feasibility study of point-of-care hepatitis C testing and rapid treatment initiation delivered adjacent to community corrections settings in Australia, via a mobile, nurse and peer-led, low-threshold model of care. More
Facilitated Telemedicine Boosts Long-Term Recovery for Patients with HCV and OUD, with Andrew Talal, MD
Integrating facilitated telemedicine into opioid treatment programs led to sustained virological response, improved patient satisfaction, and long-term health gains 5 years post-cure. More
Hepatitis C Cure Can Be Assessed 4 Weeks After Treatment
Measuring HCV viral load at 4 weeks posttreatment predicts a cure as well as sustained virological response at 12 weeks. More
A Decentralized Point of Service Triple Prevention and Treatment Model for Hepatitis B, C and HIV in PWID in South Africa
The model demonstrated a feasible approach to improve access for PWID in South Africa to viral hepatitis and HIV care. More
